Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy

被引:44
|
作者
Fuhrmann, N. [1 ]
Alavi, M. V. [1 ]
Bitoun, P. [2 ]
Woernle, S. [3 ]
Auburger, G. [4 ]
Leo-Kottler, B. [5 ]
Yu-Wai-Man, P. [6 ,7 ]
Chinnery, P. [6 ]
Wissinger, B. [1 ]
机构
[1] Univ Clin Tuebingen, Mol Genet Lab, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany
[2] CHU Paris Nord, Genet Med Hop Jean Verdier, Bondy, France
[3] Clin Ctr Traunstein, Dept Pediat, Traunstein, Germany
[4] Univ Clin Frankfurt, Dept Neurol, Sect Mol Neurogenet, Frankfurt, Germany
[5] Univ Clin Tuebingen, Ctr Ophthalmol, Univ Eye Hosp, Tubingen, Germany
[6] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England
[7] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
CHROMOSOME 3Q REGION; LINKAGE ANALYSIS; MUTATIONS; GENE; CHILDHOOD; DISEASE;
D O I
10.1136/jmg.2008.062570
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Autosomal dominant optic atrophy (ADOA) is considered as the most common form of hereditary optic neuropathy. Although genetic linkage studies point to the OPA1 locus on chromosome 3q28-q29 as by far the most common gene locus, previous screening studies-based on sequencing of the coding exons-detected OPA1 mutations in only 32-70% of ADOA patients. We therefore hypothesised that larger deletions or duplications that remained undetected in previous screening approaches may substantially contribute to the prevalence of OPA1 mutations in ADOA. Methods: 42 independent ADOA patients were analysed for the presence of genomic rearrangements in OPA1 by means of multiplex ligation probe amplification (MLPA). Deletions or duplications were confirmed either by long distance polymerase chain reaction (PCR) and breakpoint sequencing or loss of heterozygosity analyses with flanking microsatellite markers. Patients underwent ophthalmological examination including visual acuity, colour vision testings, perimetry and funduscopy. Results: We identified genomic rearrangements in 8 of 42 patients, including single exon deletions of exon 9 and exon 24, respectively, a deletion of exons 1-5, two different deletions of the complete OPA1 gene as well as a duplication of the exons 7-9, with the latter being present in three unrelated families. Patients' phenotypes were highly variable, similar to patients with point mutation in OPA1. Discussion: Our findings show that gross genomic aberrations at the OPA1 gene locus are frequent in ADOA and substantially contribute to the spectrum and prevalence of OPA1 mutations in ADOA patients. They further strengthen the hypothesis that haploinsufficiency is a major pathomechanism in OPA1 associated ADOA.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 50 条
  • [31] Mitochondrial dysfunction in an Opa1Q285STOP mouse model of dominant optic atrophy results from Opa1 haploinsufficiency
    Kushnareva, Y.
    Seong, Y.
    Andreyev, A. Y.
    Kuwana, T.
    Kiosses, W. B.
    Votruba, M.
    Newmeyer, D. D.
    CELL DEATH & DISEASE, 2016, 7 : e2309 - e2309
  • [32] Loss of functional OPA1 unbalances redox state: implications in dominant optic atrophy pathogenesis
    Millet, Aurelie M. C.
    Bertholet, Ambre M.
    Daloyau, Marlene
    Reynier, Pascal
    Galinier, Anne
    Devin, Anne
    Wissinguer, Bernd
    Belenguer, Pascale
    Davezac, Noelie
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (06): : 408 - 421
  • [33] OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy
    Yu-Wai-Man, Patrick
    Trenell, Michael I.
    Hollingsworth, Kieren G.
    Griffiths, Philip G.
    Chinnery, Patrick F.
    BRAIN, 2011, 134
  • [34] OPA1 analysis in an international series of probands with bilateral optic atrophy
    Liskova, Petra
    Tesarova, Marketa
    Dudakova, Lubica
    Svecova, Stepanka
    Kolarova, Hana
    Honzik, Tomas
    Seto, Sharon
    Votruba, Marcela
    ACTA OPHTHALMOLOGICA, 2017, 95 (04) : 363 - 369
  • [35] Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants
    Li, Huajin
    Jones, Evan M.
    Li, Hui
    Yang, Lizhu
    Sun, Zixi
    Yuan, Zhisheng
    Chen, Rui
    Dong, Fangtian
    Sui, Ruifang
    OPHTHALMIC GENETICS, 2018, 39 (05) : 569 - 576
  • [36] Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations
    Nasca, Alessia
    Rizza, Teresa
    Doimo, Mara
    Legati, Andrea
    Ciolfi, Andrea
    Diodato, Daria
    Calderan, Cristina
    Carrara, Gianfranco
    Lamantea, Eleonora
    Aiello, Chiara
    Di Nottia, Michela
    Niceta, Marcello
    Lamperti, Costanza
    Ardissone, Anna
    Bianchi-Marzoli, Stefania
    Iarossi, Giancarlo
    Bertini, Enrico
    Moroni, Isabella
    Tartaglia, Marco
    Salviati, Leonardo
    Carrozzo, Rosalba
    Ghezzi, Daniele
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12 : 1 - 10
  • [37] Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics
    Alavi, Marcel V.
    Fuhrmann, Nico
    MOLECULAR NEURODEGENERATION, 2013, 8
  • [38] Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy
    de Muijnck, Cansu
    Haer-Wigman, Lonneke
    van Everdingen, Judith A. M.
    Lushchyk, Tanya
    Heutinck, Pam A. T.
    van Dooren, Marieke F.
    Kievit, Anneke J. A.
    Verhoeven, Virginie J. M.
    Simon, Marleen E. H.
    Wasmann, Rosemarie A.
    Notting, Irene C.
    De Baere, Elfride
    Walraedt, Sophie
    De Zaeytijd, Julie
    van den Broeck, Filip
    Leroy, Bart P.
    Boon, Camiel J. F.
    van Genderen, Maria M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [39] First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report
    Weisschuh, Nicole
    Mazzola, Pascale
    Heinrich, Tilman
    Haack, Tobias
    Wissinger, Bernd
    Tonagel, Felix
    Kelbsch, Carina
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [40] Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells
    Venkatesh, Aditya
    McKenty, Taylor
    Ali, Syed
    Sonntag, Donna
    Ravipaty, Shobha
    Cui, Yanyan
    Slate, Deirdre
    Lin, Qian
    Christiansen, Anne
    Jacobson, Sarah
    Kach, Jacob
    Lim, Kian Huat
    Srinivasan, Vaishnavi
    Zinshteyn, Boris
    Aznarez, Isabel
    Huryn, Laryssa A.
    Li, Zhiyu
    Hufnagel, Robert B.
    Liau, Gene
    Anderson, Karen
    Hoger, Jeff
    NUCLEIC ACID THERAPEUTICS, 2024, 34 (05) : 221 - 233